Striatal microinjections of nitric oxide synthase inhibitors and l-arginine fail to exert effects on paroxysmal dystonia in the dtsz mutant

Neuroscience Letters

Volumn 398, Issue 1-2, 2006, Pages 97-101

  Sander, Svenja Esther ^a   Richter, Angelika ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Animal models; Dyskinesia; Dystonia; Movement disorder; Neuronal nitric oxide synthase

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; 7 NITROINDAZOLE; ARGININE; N OMEGA PROPYLARGININE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CORPUS STRIATUM; DENSITY; DISEASE SEVERITY; DRUG EFFECT; DYSTONIA; HAMSTER; HEMISPHERE; INTERNEURON; MICROINJECTION; MUTANT; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

ANIMALS; ARGININE; CORPUS STRIATUM; CRICETINAE; DYSTONIA; INDAZOLES; MICROINJECTIONS; MOTOR ACTIVITY; MUTATION; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE I;

EID: 33646011966     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2005.12.068     Document Type: Article

References (34)

1. Baraban S.C. Neuropeptide Y and epilepsy: recent progress, prospects and controversies. Neuropeptides 38 (2004) 261-265
2. Bhatia K.P., and Marsden C.D. The behavioural and motor consequences of focal lesions of the basal ganglia in man. Brain 117 (1994) 859-876
3. Bogdanov M.B., and Wurtman R.J. Possible involvement of nitric oxide in NMDA-induced glutamate release in the rat striatum: an in vivo microdialysis study. Neurosci. Lett. 221 (1997) 197-201
4. Burgunder J., Richter A., and Löscher W. Expression of cholecystokinin, somatostatin, thyrotropin-releasing hormone, glutamic acid decarboxylase and tyrosine hydroxylase genes in the central nervous motor systems of the genetically dystonic hamster. Exp. Brain Res. 129 (1999) 114-120
5. Burlet S., Leger L., and Cespuglio R. Nitric oxide and sleep in the rat: a puzzling relationship. Neuroscience 92 (1999) 627-639
6. Caillard O., Moreno H., Schwaller B., Llano I., Celio M.R., and Marty A. Role of the calcium-binding protein parvalbumin in short-term synaptic plasticity. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 13372-13377
7. Centonze D., Gubellini P., Pisani A., Bernardi G., and Calabresi P. Dopamine, acetylcholine and nitric oxide systems interact to induce corticostriatal synaptic plasticity. Rev. Neurosci. 14 (2003) 207-216
8. Chung K.K., Thomas B., Li X., Pletnikova O., Troncoso J.C., Marsh L., Dawson V.L., and Dawson T.M. S-nitrosylation of parkin regulates ubiquitination and compromises parkin's protective function. Science 304 (2004) 1328-1331
9. Deckel A.W., Tang V., Nuttal D., Gary K., and Elder R. Altered neuronal nitric oxide synthase expression contributes to disease progression in Huntington's disease transgenic mice. Brain Res. 939 (2002) 76-86
10. Fahn S., Bressman S.B., and Marsden C.D. Classification of dystonia. Adv. Neurol. 78 (1998) 1-10
11. Ferraro G., and Sardo P. Nitric oxide and brain hyperexcitability. In Vivo 18 (2004) 357-366
12. Figueredo-Cardenas G., Morello M., Sancesario G., Bernardi G., and Reiner A. Colocalization of somatostatin, neuropeptide Y, neuronal nitric oxide synthase and NADPH-diaphorase in striatal interneurons in rats. Brain Res. 735 (1996) 317-324
13. Friedman Y., Richter A., Raymond R., Löscher W., and Nobrega J.N. Regional decreases in NK-3, but not NK-1 tachykinin receptor binding in dystonic hamster (dt(sz)) brains. Neuroscience 112 (2002) 639-645
14. Gernert M., Bennay M., Fedrowitz M., Rehders J.H., and Richter A. Altered discharge pattern of basal ganglia output neurons in an animal model of idiopathic dystonia. J. Neurosci. 22 (2002) 7244-7253
15. Gernert M., Hamann M., Bennay M., Löscher W., and Richter A. Deficit of striatal parvalbumin-reactive GABAergic interneurons and decreased basal ganglia output in a genetic rodent model of idiopathic paroxysmal dystonia. J. Neurosci. 20 (2000) 7052-7058
16. Hamann M., and Richter A. Effects of striatal injections of GABA(A) receptor agonists and antagonists in a genetic animal model of paroxysmal dystonia. Eur. J. Pharmacol. 443 (2002) 59-70
17. Hamann M., and Richter A. Striatal increase of extracellular dopamine levels during dystonic episodes in a genetic model of paroxysmal dyskinesia. Neurobiol. Dis. 16 (2004) 78-84
18. Hamann M., Sander S.E., and Richter A. Age-dependent alterations of striatal calretinin interneuron density in a genetic animal model of primary paroxysmal dystonia. J. Neuropathol. Exp. Neurol. 64 (2005) 776-781
19. Kammann S.E., Hamann M., and Richter A. Effects of striatal injections of glutamate receptor antagonists in a genetic animal model of primary paroxysmal dystonia. Naunyn Schmiedebergs Arch. Pharmacol. 367 Suppl. 1 (2003) S. R88 (338)
20. Kawaguchi Y., Wilson C.J., Augood S.J., and Emson P.C. Striatal interneurones: chemical, physiological and morphological characterization. Trends Neurosci. 18 (1995) 527-535
21. Kiss J.P., and Vizi E.S. Nitric oxide: a novel link between synaptic and nonsynaptic transmission. Trends Neurosci. 24 (2001) 211-215
22. Kramer P.L., Bressman S.B., Fahn S., Ozelius L., and Breakefield X.O. The genetics of dystonia. In: King J., Calne D.B., and Tsui J.K.C. (Eds). Handbook of Dystonia (1995), Marcel Dekker, New York 43-58
23. Lipton S.A., Choi Y.B., Pan Z.H., Lei S.Z., Chen H.S., Sucher N.J., Loscalzo J., Singel D.J., and Stamler J.S. A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature 364 (1993) 626-632
24. Löscher W., Fisher Jr. J.E., Schmidt D., Fredow G., Honack D., and Iturrian W.B. The sz mutant hamster: a genetic model of epilepsy or of paroxysmal dystonia?. Mov. Disord. 4 (1989) 219-232
25. L.P. Morin, R.I. Wood, A. Stereotoxic Atlas of the Golden Hamster Brain, Academic Press, 2001, 146 pp.
26. Nardocci N., Fernandez-Alvarez E., Wood N.W., Spacy S.D., and Richter A. The paroxysmal dyskinesias. In: Guerrini R., Aicardi J., Andermann F., and Hallett M. (Eds). Epilepsy and Movement Disorders (2002), Cambridge University Press, Cambridge 125-139
27. Nobrega J.N., Richter A., Jiwa D., Raymond R., and Löscher W. Alterations in N-methyl-d-aspartate receptor binding in dystonic hamster brains. Brain Res. 744 (1997) 161-165
28. Rehders J.H., Löscher W., and Richter A. Evidence for striatal dopaminergic overactivity in paroxysmal dystonia indicated by microinjections in a genetic rodent model. Neuroscience 97 (2000) 267-277
29. Richter A., and Löscher W. Pathology of idiopathic dystonia: findings from genetic animal models. Prog. Neurobiol. 54 (1998) 633-677
30. Richter A., Löschmann P.A., and Löscher W. Antidystonic efficacy of nitric oxide synthase inhibitors in a rodent model of primary paroxysmal dystonia. Br. J. Pharmacol. 131 (2000) 921-926
31. Sander S.E., Hamann M., and Richter A. Age-related changes in striatal NOS-immunoreactive interneurons in the dystonic dt(sz) mutant hamster. Neuropathol. Appl. Neurobiol. 32 (2006) 74-82
32. Sasaki M., Gonzalez-Zulueta M., Huang H., Herring W.J., Ahn S., Ginty D.D., Dawson V.L., and Dawson T.M. Dynamic regulation of neuronal NO synthase transcription by calcium influx through a CREB family transcription factor-dependent mechanism. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 8617-8622
33. West A.R., and Galloway M.P. Endogenous nitric oxide facilitates striatal dopamine and glutamate efflux in vivo: role of ionotropic glutamate receptor-dependent mechanisms. Neuropharmacology 36 (1997) 1571-1581
34. West A.R., and Grace A.A. Striatal nitric oxide signaling regulates the neuronal activity of midbrain dopamine neurons in vivo. J. Neurophysiol. 83 (2000) 1796-1808